Emerging markets drugs worth $3B could be next on Takeda’s chopping board: report

21st January 2019 Uncategorised 0

Looking to trade in some assets outside of Japan to fund its Shire takeover, Takeda is reportedly eyeing a sale of some emerging-market drugs gained in its $14 billion acquisition of Swiss drugmaker Nycomed in 2011.

More: Emerging markets drugs worth B could be next on Takeda’s chopping board: report
Source: fierce